Gene · 9738
CCP110: centriolar coiled-coil protein 110
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CCP110: centriolar coiled-coil protein 110. Genes, record 9738. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9738
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O43303 | Centriolar coiled-coil protein of 110 kDa | 1,012 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents12
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 10452 | O43303 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10774 | O43303 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 10774 | O43303 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 10452 | O43303 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 6654 | O43303 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 13849 | O43303 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 116820 | O43303 | Espacenet |
| US 10463751 B2 | 2019-11-05 | 6654 | O43303 | Espacenet |
| JP 2018023373 A | 2018-02-15 | 29381 | O43303 | Espacenet |
| US 9572897 B2 | 2017-02-21 | 6654 | O43303 | Espacenet |
1 to 10 of 12
See all 12 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants548
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CCP110 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| ZIABC011398 | Regulation of Ciliogenesis and Ciliary-related signaling | 7 | 2025 |
| R01GM088253 | Template-based replication of the centriole organelle | 6 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 3 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 3 | 2025 |
| R01DK099160 | Molecular dissection of the ciliary gate | 3 | 2025 |
| R35GM144102 | Mechanisms of membrane trafficking in endocytic and non-endocytic pathways | 3 | 2025 |
| ZIABC011459 | Control of centrosome biogenesis | 3 | 2025 |
1 to 10 of 548Source NIH's project files
See all 548 nih grantsPapers747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant PCM1 accumulation in Trisomy 21 mislocalizes E3 ligases, delaying primary ciliogenesis. | bioRxiv | 2026 | 42779918 | PubTator, text mining | PubMed |
| Divergent microtubule-organizing center strategies in mammalian gametogenesis. | Trends Open | 2026 | 42761981 | PubTator, text mining | PubMed |
| Enhancer collapse dictates PKHD1 silencing and centrosome-mediated chromosomal instability and metastasis in clear cell renal cell carcinoma. | Exp Cell Res | 2026 | 42586231 | PubTator, text mining | PubMed |
| Characterization of membrane structures regulating primary ciliogenesis by quantitative isotropic ultrastructure imaging. | Nat Commun | 2026 | 42288497 | PubTator, text mining | PubMed |
| Nek1 defines a branch of centriolar microtubule length control parallel to CP110-Cep97. | Nat Commun | 2026 | 42265085 | PubTator, text mining | PubMed |
| Methods to Determine the Role of MIF in Cilia Biogenesis. | Methods Mol Biol | 2026 | 42129126 | PubTator, text mining | PubMed |
| Development of Potent and Cell Active 5-Azaindole-Based Tau Tubulin Kinase Inhibitors. | bioRxiv | 2026 | 42094407 | PubTator, text mining | PubMed |
| KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma. | Cancer Med | 2026 | 41748316 | PubTator, text mining | PubMed |
| The γ-TuRC: mastermind of multipurpose actions at the centrosome. | Cell Mol Life Sci | 2026 | 41711931 | PubTator, text mining | PubMed |
| Emerging roles of the ciliary-mitochondrial axis in cellular homeostasis and neuroprotection. | Mol Neurodegener Adv | 2025 | 42751568 | PubTator, text mining | PubMed |
1 to 10 of 747
See all 747 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9738
GET https://conductscience.org/api/genes/v1/9738/patents